Similar articles

• [Effect of Briserin on hypertensive patients with and without diabetes and hypertensive patients with normal and disordered kidney function].

  Weisse C, Kühns K. Weisse C, et al. Med Welt. 1975 Jan 10;26(2):82-3. Med Welt. 1975. PMID: 803604 German. No abstract available.
• [Use of DCR-515 in the treatment of arterial hypertension].

  da Cunha GP, Riskala R, Mulinari AS. da Cunha GP, et al. Hospital (Rio J). 1968 Dec;74(6):2061-72. Hospital (Rio J). 1968. PMID: 4977024 Clinical Trial. Portuguese. No abstract available.
• [Ambulatory long-term treatment of hypertension with Briserin mite].

  Feuser J. Feuser J. Fortschr Med. 1974 May 23;92(15):665-9. Fortschr Med. 1974. PMID: 4208358 Clinical Trial. German. No abstract available.
• [Glomerular filtrate, renal plasma flow, and sodium excretion in hypertensive patients before and following antihypertensive treatment with combination preparations].

  Habermann W, Stumpe KO, Krück F. Habermann W, et al. Med Klin. 1972 Oct 20;67(42):1363-7. Med Klin. 1972. PMID: 4629612 German. No abstract available.
• [When and why to start drug therapy in essential hypertension].

  Oliva G, Fallani P, Mete A, Covello R, Avallone A. Oliva G, et al. Clin Ter. 1987 Oct 15;123(1):51-5. Clin Ter. 1987. PMID: 2972467 Review. Italian. No abstract available.